General MedicationsORALGeneric

LO LARIN FE

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Standard Dose

0.01MG,0.01MG;1MG,N/A

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: None (Tentative Approval)

Summary

Approval overview LO LARIN FE is listed in Drugs@FDA under application 208661 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ETHINYL ESTRADIOL; NORETHINDRONE ACETATE Form and strength TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A Sponsor NOVAST LABS LTD Submission history Latest submission status date: 2016-12-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview LO LARIN FE is listed in Drugs@FDA under application 208661 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ETHINYL ESTRADIOL; NORETHINDRONE ACETATE Form and strength TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A Sponsor NOVAST LABS LTD Submission history Latest submission status date: 2016-12-20 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.